Development of high-grade osteosarcoma in a patient with recurrent giant cell tumor of the ischium while receiving treatment with denosumab

Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone

(2016) Frank Traub et al.   EUROPEAN JOURNAL OF CANCER

Giant cell rich osteosarcoma revisited—diagnostic criteria and histopathologic patterns, Ki67, CDK4, and MDM2 expression, changes in response to bisphosphonate and denosumab treatment

(2016) Louis Tsun Cheung Chow   VIRCHOWS ARCHIV

Safety of Denosumab Versus Zoledronic Acid in Patients with Bone Metastases: A Meta-Analysis of Randomized Controlled Trials

(2016) Fengxia Chen et al.   Oncology Research and Treatment

Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma

(2015) Arjen H.G. Cleven et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Surgical Downstaging in an Open-Label Phase II Trial of Denosumab in Patients with Giant Cell Tumor of Bone

(2015) Piotr Rutkowski et al.   ANNALS OF SURGICAL ONCOLOGY

Crosstalk between bone niche and immune system: Osteoimmunology signaling as a potential target for cancer treatment

(2015) Carmen Criscitiello et al.   CANCER TREATMENT REVIEWS

A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With Denosumab

(2015) Luis A. Aponte-Tinao et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

MDM2 and CDK4 expression in periosteal osteosarcoma

(2015) Alberto Righi et al.   HUMAN PATHOLOGY

USP6 gene rearrangements occur preferentially in giant cell reparative granulomas of the hands and feet but not in gnathic location

(2014) Narasimhan P. Agaram et al.   HUMAN PATHOLOGY

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

(2013) Sant Chawla et al.   LANCET ONCOLOGY

Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone

(2012) D. G. Branstetter et al.   CLINICAL CANCER RESEARCH

Safety of denosumab in giant-cell tumour of bone

(2010) David Thomas et al.   LANCET ONCOLOGY

Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer

(2009) Matthew R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer

(2008) Georgiana K. Ellis et al.   JOURNAL OF CLINICAL ONCOLOGY

Giant cell tumor of bone express p63

(2008) Brendan C Dickson et al.   MODERN PATHOLOGY